May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Enrolling for the ComboMATCH Treatment Trial E5 – ECOG-ACRIN Cancer Research Group
Apr 15, 2025, 07:21

Enrolling for the ComboMATCH Treatment Trial E5 – ECOG-ACRIN Cancer Research Group

ECOG-ACRIN Cancer Research Group shared a post on X:

“ComboMATCH Treatment Trial E5, led by Kristen Spencer, Perlmutter Cancer Center at NYU Langone Health and Dustin Deming, UW Health – Carbone Cancer Center, is a randomized phase 2 study of sotorasib with or without panitumumab in advanced solid tumours.

Learn more here.”

More posts featuring ECOG-ACRIN Cancer Research Group.